Type 2 transglutaminase in exosome, a potential molecular marker for sensitivity of oral squamous cell carcinoma (OSCC) cells in cisplatin treatment

  • Lee, Wai-Leng (Primary Chief Investigator (PCI))
  • Chow, Sek C (Chief Investigator (CI))
  • Paterson, Ian Charles (Chief Investigator (CI))
  • Hing, Goh Bey (Chief Investigator (CI))

    Project: Research

    Project Details

    StatusActive
    Effective start/end date1/09/1931/05/23